Search results
Tension in EU bond market relaxes
The Forex Market· 5 days agoEU mid-market update: Tension in EU bond market relaxes; US markets sit at record highs as traders bet on Sept rate cut for Fed ahead of more speakers.
‘I’ve saved £44,000 – can I retire as a millionaire at 60?’
Daily Telegraph· 3 days agoCollective investments simplify things by providing built-in diversification and can save you the...
‘I’ve saved £44,000 – can I retire as a millionaire at 60?’
The Telegraph· 3 days agoCollective investments simplify things by providing built-in diversification and can save you the...
Merck's (MRK) 21-Valent Pneumococcal Jab Gets FDA Approval
Zacks via Yahoo Finance· 4 days agoMerck's (MRK) 21-valent pneumococcal conjugate vaccine, Capvaxive/V116, becomes the first PCV...
Unveiling the Medical Democide in the UK
Mercola· 17 hours ago"Playing God: An Investigation into Medical Democide in the UK" is a documentary film that explores allegations of harmful medical practices and policies in the U.K. health care system. Directed ...
Radioactive drugs strike cancer with precision
Ars Technica· 2 days agoOn a Wednesday morning in late January 1896 at a small light bulb factory in Chicago, a middle-aged woman named Rose Lee found herself at the heart of a...
Is Immunotherapy for Cat Allergy Effective?
Medscape· 5 days agoIn the field of allergology, desensitization to animals, specifically cats, is rarely prescribed. Has allergen immunotherapy (IT), which has long been...
US Drug Negotiations Plan Shifts Focus for Rare Disease Programs
Bloomberg Law· 6 days agoThe rare disease community is pushing for changes in the Inflation Reduction Act’s drug price-setting scheme as it leads more drugmakers and investors to reconsider development of drugs to treat ...
Rethinking Clinical Trial Design and Cure in NSCLC
Medscape· 3 days agoMark Kris discusses clinical trial design and the goal of cure in non–small cell lung cancer.
Truqap Combo Earns EU Approval for Advanced Breast Cancer
Medscape· 2 days agoThe approval is based on positive results from the phase 3 CAPItello-291 trial.
